Text Size

Oxidative stress in retinal diseases

Nishimura Y., Hara H., Kondo M., Hong S., Matsugi T.


  • 2017
  • Oxidative Medicine and Cellular Longevity
View publication
  • Therapeutic Area

    Back of the eye (BOTE)

  • Categories

    Disease understanding (epidemiology, diagnosis, QoL, Biomarkers…)

  • Affiliations

    Department of Molecular and Cellular Pharmacology, Pharmacogenomics and Pharmacoinformatics, Mie University, Graduate School of Medicine, Mie, 514-8507, Japan; Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, 501-1196, Japan; Department of Ophthalmology, Mie University, Graduate School of Medicine, Tsu, Mie, 514-8507, Japan; Department of Ophthalmology, Yonsei University, College of Medicine, Seoul, 03722, South Korea; Non-Clinical Research, Santen Pharmaceutical Co. Ltd., Osaka, 530-8552, Japan

Related Publications

Valosin-containing protein modulator KUS121 protects retinal neurons in a rat model of anterior ischemic optic neuropathy

Kikkawa C., Ikeda H.O., Hata M., Iwai S., Tsujikawa A.


Rapid and efficient generation of mature retinal organoids derived from human pluripotent stem cells via optimized pharmacological modulation of Sonic hedgehog, activin A, and retinoic acid signal transduction

Matsushita T.; Onishi A.; Matsuyama T.; Masuda T.; Ogino Y.; Kageyama M.; Takahashi M.; Uchiumi F.


Rotenone-Induced Optic Nerve Damage and Retinal Ganglion Cell Loss in Rats

Yamamoto Y.; Taniguchi T.; Shimazaki A.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022